The underlying pathological changes observed in patients with FTD are classified based on the constituents of the intra-neuronal protein aggregations, including tau, tau-negative but ubiquitin-positive inclusions, transactive response DNA-binding protein 43 kDa (TDP-43), and fused-in-sarcoma protein (FUS) [7]. Here, MAPT is linked to frontotemporal dementia.